WHO GRADE 2 GLIOMA

Clinical trials for WHO GRADE 2 GLIOMA explained in plain language.

Never miss a new study

Get alerted when new WHO GRADE 2 GLIOMA trials appear

Sign up with your email to follow new studies for WHO GRADE 2 GLIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 2 Not yet finished but already full! 1

Targeted drug shows promise for Hard-to-Treat brain and bile duct cancers

Disease control Ongoing

This study tests a drug called olaparib in people with advanced cancers (like brain tumors, bile duct cancer, or other solid tumors) that have a specific gene change called IDH1 or IDH2 mutation. The drug works by blocking an enzyme that cancer cells need to grow. About 89 partic…

Matched conditions: WHO GRADE 2 GLIOMA

Phase: PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control

Last updated Jun 27, 2026 14:00 UTC

WHO GRADE 2 GLIOMA

Get alerted when new WHO GRADE 2 GLIOMA trials appear

Targeted drug shows promise for Hard-to-Treat brain and bile duct cancers